FDA Approval Activities for this Drug…

Maxalt (rizatriptan benzoate) Tablets & Maxalt-MLT (orally disintegrating tablet), 5 and 10 mg, Merck NDA 20-864/S8 & 20-865/S9 4/22/02 5/2/02 Maxalt (rizatriptan benzoate) Tablets & Maxalt-MLT (orally disintegrating tablet), 5 and 10 mg, Merck NDA 20-864 & 20-865 6/29/98 6/30/98 6/30/98 4/8/99 Maxalt Indication: Migraine Maxalt (rizatriptan)5 and 10 mg, . Merck & Co., NDA 20-865/S-001 NDA 20-864/S-003

For the latest approval information and links for this API, please see the main page.